Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Professor of Oncology and Pharmacology
Director, Mayo Breast Cancer SPORE
Co-PI, Women's Cancer Program
Department of Medical Oncology
Mayo Clinic
Rochester, Minnesota
Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California
Celebrating Women Chair in Breast Cancer Research
Director, Breast Cancer Research Program
Baylor University Medical Center
Texas Oncology
US Oncology Network
Dallas, Texas
This program has been made available online.
For further information concerning Lilly grant funding,
visit www.lillygrantoffice.com.
Dr Yara Abdou discusses BRCA mutation testing and adjuvant therapy with olaparib in BRCA-mutated, HER2-negative early breast cancer, from Clinical Care Options (CCO)
Slideset from Dr Yara Abdou on adjuvant olaparib in BRCA1/2-mutated, HER2-negative early breast cancer, from Clinical Care Options (CCO)
Podcast with Dr. Nelson F. Sanchez on caring for transgender individuals, from the healthcare disparities they face to how HCPs can improve their care, from Clinical Care Options (CCO)
Review this slideset on the current treatment of cholangiocarcinoma with expert perspectives from Christine Chio, PharmD, BCOP; Lipika Goyal, MD; and Caroline Kuhlman, NP.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.